台股 » 旭富 » 個股財報 » 每股盈餘成長率(年增率)
- 股價
90.4
- 漲跌
▼0.4
- 漲幅
-0.44%
- 成交量
90張
- 產業
上市 生技醫療類股
▲1.26%
-
本地時間:13:30
旭富 (4119) 財務報表－每股盈餘成長率(年增率)
EPS成長率
EPS季增率 = (單季EPS÷上季EPS)-1。
EPS年增率 = (單季EPS÷去年同季EPS)-1。
旭富 (4119) 歷年EPS年增率
| 年度/季別 | EPS年增率 | 近4季EPS年增率 | 年度/季別 | EPS年增率 | 近4季EPS年增率 |
|---|
| 2024Q1 | -37.29% | -21.05% | 2021Q2 | -98.68% | -116% |
| 2023Q4 | -123.19% | -9.03% | 2021Q1 | -83.59% | -79.48% |
| 2023Q3 | -26.67% | 74.37% | 2020Q4 | -438.6% | -47.43% |
| 2023Q2 | 41.98% | 94.05% | 2020Q3 | -1.49% | 18.17% |
| 2023Q1 | 37.21% | 424.14% | 2020Q2 | 53.54% | 25.5% |
| 2022Q4 | -445% | 396.55% | 2020Q1 | 27.18% | 11.99% |
| 2022Q3 | 45.16% | -164.61% | 2019Q4 | -17.39% | 27.71% |
| 2022Q2 | 3175% | -231.21% | 2019Q3 | 25.63% | 74.82% |
| 2022Q1 | 0% | -63.52% | 2019Q2 | 5.32% | 164.91% |
| 2021Q4 | -94.82% | -84.66% | 2019Q1 | 167.53% | 798.7% |
| 2021Q3 | -84.34% | -135.08% | | | |
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨－2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨－2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨－2022/11/23